Elder Granger - 07 Jun 2023 Form 4 Insider Report for Better Therapeutics, Inc.

Role
Director
Signature
/s/ Mark Heinen, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
07 Jun 2023
Net transactions value
$0
Form type
4
Filing time
09 Jun 2023, 18:56:37 UTC
Previous filing
18 May 2023
Next filing
31 Jul 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BTTX Stock Option (Right to Buy) Award $0 +15,000 $0.000000 15,000 07 Jun 2023 Common Stock 15,000 $0.7700 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests in full on the earlier of the first anniversary of the grant date and the Issuer's next annual meeting of stockholders, provided that the Reporting Person continues to serve as a director of the Issuer on such vesting date. The stock option was granted on June 7, 2023.